Correlation Between Galera Therapeutics and Evelo Biosciences
Can any of the company-specific risk be diversified away by investing in both Galera Therapeutics and Evelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Galera Therapeutics and Evelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Galera Therapeutics and Evelo Biosciences, you can compare the effects of market volatilities on Galera Therapeutics and Evelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Galera Therapeutics with a short position of Evelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Galera Therapeutics and Evelo Biosciences.
Diversification Opportunities for Galera Therapeutics and Evelo Biosciences
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Galera and Evelo is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Galera Therapeutics and Evelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evelo Biosciences and Galera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Galera Therapeutics are associated (or correlated) with Evelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evelo Biosciences has no effect on the direction of Galera Therapeutics i.e., Galera Therapeutics and Evelo Biosciences go up and down completely randomly.
Pair Corralation between Galera Therapeutics and Evelo Biosciences
Given the investment horizon of 90 days Galera Therapeutics is expected to generate 0.32 times more return on investment than Evelo Biosciences. However, Galera Therapeutics is 3.13 times less risky than Evelo Biosciences. It trades about 0.07 of its potential returns per unit of risk. Evelo Biosciences is currently generating about 0.01 per unit of risk. If you would invest 185.00 in Galera Therapeutics on October 3, 2024 and sell it today you would earn a total of 73.00 from holding Galera Therapeutics or generate 39.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Galera Therapeutics vs. Evelo Biosciences
Performance |
Timeline |
Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Evelo Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Galera Therapeutics and Evelo Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Galera Therapeutics and Evelo Biosciences
The main advantage of trading using opposite Galera Therapeutics and Evelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Galera Therapeutics position performs unexpectedly, Evelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will offset losses from the drop in Evelo Biosciences' long position.Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
Evelo Biosciences vs. Aileron Therapeutics | Evelo Biosciences vs. ABVC Biopharma | Evelo Biosciences vs. Surrozen | Evelo Biosciences vs. Processa Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |